What covered companies filed with the SEC, day by day.
Nothing from your lists
+ 13 more
Nothing from your lists
Alamo Group Inc · “On September 8, 2026, Alamo Group Inc. (the “Company”), as part of its ongoing review of its product portfolio, decided to cease production of its Boxer branded line of products.”¶1
Synergy CHC Corp. · “On September 4, 2026, Synergy CHC Corp. (the “Company”) filed a voluntary petition for relief under chapter 11 of title 11 of the United States Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Columbia (the “Bankruptcy Court”).”¶1
Sangamo Therapeutics, Inc · “On August 20, 2026, the Court entered a Sale Order authorizing the sale of the Lilly Assets pursuant to the terms of the Asset Purchase Agreement (as defined below) (Docket No. 362).”¶1
Nothing from your lists
Nothing from your lists
Nothing from your lists
Nothing from your lists
On September 8, 2026, Alamo Group Inc. decided to cease production of its Boxer branded line of products.¶1
The Company estimates that it will incur approximately $7.0 million to $10.0 million in charges in the third quarter of 2026 in connection with this action.¶1
The Company does not expect material cash expenditures in connection with these impairment charges.¶2
On August 25, 2026, Boston Scientific identified a cybersecurity incident affecting certain information technology systems and causing a global disruption to operations.¶1
The incident caused a network outage that affected manufacturing and the processing and shipping of customer orders; the investigation remains ongoing.¶2
The Company determined the incident is likely to have a material impact on results of operations for the third quarter and full year 2026 and is unlikely to meet previously provided guidance.¶3
On September 4, 2026, Synergy CHC Corp. filed a voluntary chapter 11 petition in the United States Bankruptcy Court for the District of Columbia.¶1
The chapter 11 case is captioned In re Synergy CHC Corp., Case No. 26-465-ELG, and the Company anticipates filing a plan of liquidation or reorganization within the forthcoming 120-day period.¶2¶3
Lauren P. Berret became chief restructuring officer on August 26, 2026, four directors resigned on September 4, 2026, Jack Ross became the sole director, and Alfred Baumeler resigned as President on August 31, 2026.¶4¶5¶6¶7
On September 4, 2026, the Company completed the sale of its technology platforms and related rights to Lilly for $50 million in cash and the assumption of certain specified liabilities.¶2¶3
The sale included the AAV capsid engineering, zinc finger protein, and Modular Integrase genome editing platforms, the ST-506 prion disease program, related intellectual property, and certain outlicensing payment rights.¶2
The Company filed a voluntary Chapter 11 petition on June 23, 2026, and continued operating as a debtor-in-possession under the Court’s jurisdiction.¶4
The monthly operating report for July 2026 reported $18,058,990 in receipts, $15,534,279 in disbursements, and a $-11,165,298 profit (loss).¶5¶6¶7
Cayson Acquisition Corp and Mango Financial Group Limited entered into a termination agreement that mutually terminated their Merger Agreement.¶2¶1
Mango agreed to pay certain Company expenses, and the Company will issue a promissory note payable without interest upon consummation of an initial business combination.¶1
If the Company lacks cash to repay the notes, it may convert their principal balances into units at $10.00 per unit.¶1¶3
The SPAC will resume its search for a target business for an initial business combination.¶4
The MSA was terminated effective as of the close of business on September 3, 2026, and the parties waived the 180-day notice requirement; the Company did not incur any material early termination penalties.¶1
The Company Subsidiary entered into a new services agreement with American Validator LLC effective September 4, 2026, for a fee of 1.50% of staking rewards on Company-staked Ethereum.¶2
On September 7, 2026, Beyond Home Services, LLC and F9 Investments, LLC mutually agreed to terminate the July 23, 2026 Merger Agreement because certain closing conditions were not satisfied.¶2¶3
The Merger Agreement became null and void, the companies will operate independently, and Neighborhood will not proceed with the acquisition or enter into a commercial or strategic collaboration with F9.¶3¶4
As of August 31, 2026, Neighborhood had approximately 97 million shares of common stock issued and outstanding, and no shares will be issued or acquisition capital deployed for F9.¶5¶6
The Company closed the offering on September 8, 2026, issuing 1,375,000 shares of CHAD at $8.00 per share.¶1¶2
Net proceeds were approximately $10.3 million and were used for general corporate purposes, including working capital, acquiring SOL and strategic initiatives.¶2
CHAD has an initial annual dividend rate of 13.0%, a stated amount of $10.00 per share, and is listed on The Nasdaq Capital Market under CHAD.¶3¶4¶5¶6¶7
The Company’s Certificate of Designation designated 2,200,000 shares of CHAD, which ranks senior to common stock for dividends and liquidation distributions.¶3¶8
On September 3, 2026, La Rosa Holdings Corp. filed an amendment to effect a 1-for-6 reverse stock split effective at 12:01 a.m. (New York time) on September 8, 2026.¶2
The reverse stock split reduced outstanding Common Stock from approximately 3.4 million shares to approximately 569 thousand shares, while authorized shares remained 2 billion 50 million (2,050,000,000) and par value remained $0.0001 per share.¶1
The Common Stock began trading on a reverse stock split-adjusted basis on The Nasdaq Capital Market on September 8, 2026, under the symbol “LRHC” and new CUSIP number 50172T509.¶3¶4
The board approved a 1-for-100 reverse share split on August 20, 2026, and shareholders holding a majority of the issued and outstanding shares approved the Reverse Share Split and Round Up by written consent.¶1
Outstanding Common Stock will be reduced from approximately 19.99 million shares to approximately 0.20 million shares, and adjusted trading begins September 9, 2026, under ticker symbol “JFIL”.¶2
The board appointed David Garcia Rios as a Class II director effective immediately, with his term expiring at the Company’s 2027 annual meeting of stockholders.¶1
SFF designated Garcia Rios as its Board nominee, while the Investors purchased approximately $134 million in aggregate of pre-funded warrants and SFF purchased approximately $16 million.¶2¶3
SFF beneficially owned approximately 9.99% of the Company’s outstanding common stock, and Garcia Rios will receive annual cash compensation of $40,000.¶3¶4
The Company withdrew the designations for its Series A through Series F preferred stock, which had no shares outstanding, returning the shares to authorized preferred stock and leaving 5,000,000 shares available for designation and issuance.¶5¶6¶7¶8¶9¶10¶11¶12
The Company committed to contribute $4.0 million to the Mira JV for an approximately 42% preferred equity interest.¶2
The Company will receive a preferred return of 6% of its invested preferred equity paid no less frequently than quarterly, and an additional accrued preferred return of 9% paid upon exit.¶3
The Operating Partnership agreed to provide a limited guaranty for an approximate $13.5 million construction loan to Mira JV, with closing expected within 30 days.¶4
The Agreement for the Aubrey, Texas property was reinstated with the sales price reduced from $ $5,494,444 to $5,404,864, while the Company sold the Brookfield Property for $10,100,000.¶5¶1
Franklin Electric acquired all outstanding shares of Cat Pumps on September 4, 2026, providing approximately $350 million in cash and performance-based restricted stock units with an aggregate target value of $25 million.¶1¶2
Cat Pumps generated approximately $115 million in revenue and $45 million in Adjusted EBITDA in 2025.¶3
Franklin Electric funded the transaction with available cash and borrowings under existing credit facilities, and will report Cat Pumps in its Energy Systems segment under the Cat Pumps brand.¶4
On September 8, 2026, AEVEX Corp. completed its previously disclosed acquisition of Maritime Applied Physics, LLC from Black Sea Technologies, LLC under the August 12, 2026 Agreement and Plan of Reorganization.¶1
The closing merger consideration was based on a total enterprise value of $600,000,000 and included 12,727,273 Class A common shares valued at $350,000,000, with the balance paid in cash subject to adjustments.¶2
The closing merger consideration is subject to a post-closing adjustment of up to $5,000,000, which was deposited at closing with an escrow agent.¶3
The Seller may earn $50,000,000 in contingent consideration through December 31, 2027 if the specified $28.00 share-price condition and either the GARC/CHASER or GARC/CHASER/COMET revenue and gross-profit conditions are met.¶4
On September 1, 2026, Solaris entered into the Merger Agreement, completed the Mergers, and indirectly acquired 100% of Omega’s equity interests.¶1¶2¶3
The Shareholder received 3,599,199 shares of Class A common stock and approximately $77 million in cash, subject to customary post-closing adjustments.¶4
In connection with the Acquisition, Omega entered into a Master Lease with Bennett Acquisitions, LLC for certain properties used in its operations.¶5
The Company issued the Equity Consideration to the Shareholder in reliance on the Securities Act Section 4(a)(2) exemption from registration.¶6